The C-terminus of murine S100A9 inhibits hyperalgesia and edema induced by jararhagin

Peptides

Volumn 25, Issue 1, 2004, Pages 81-89

  Dale, Camila Squarzoni ^a   Gonçalves, Luis Roberto De Camargo ^a   Juliano, Luiz ^b   Juliano, Maria Aparecida ^b   Moura Da Silva, Ana Maria ^a   Giorgi, Renata ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Edema; Hyperalgesia; Jararhagin; MRP 14; Papain; S100A9

Indexed keywords

HISTIDYLGLUTAMYLLYSYLLEUCYLHISTIDYLGLUTAMYLASPARAGINYLASPARAGINYLPROLYLARGI NYLGLYCYLHISTIDYLGLYCYLHISTIDYLSERYLHISTIDYLGLYCYLLYSYLGLYCINE; PAPAIN; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BLEEDING; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CATALYST; CONCENTRATION RESPONSE; CONTROLLED STUDY; EDEMA; HYDROLYSIS; HYPERALGESIA; MALE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RAT;

ANIMALS; CALGRANULIN B; CROTALID VENOMS; EDEMA; HYPERALGESIA; MALE; METALLOENDOPEPTIDASES; MICE; PLATELET AGGREGATION INHIBITORS; RATS; RATS, WISTAR; TIME FACTORS;

MURINAE;

EID: 1542315482     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2003.12.008     Document Type: Article

References (63)

1. Aguiar-Passeti T., Postol E., Sorg C., Mariano M. Epithelioid cells from foreign-body granuloma selectively express the calcium-binding protein MRP-14, a novel down-regulatory molecule of macrophage activation. J. Leukoc. Biol. 62:1997;852-858.
2. Barret AJ, Rawlings ND, Woissner JF. Cysteine Peptidases. In: Handbook of proteolytic enzymes. New York: Academic Press; 1998. p. 543-796.
3. Bjarnason J.B., Fox J.W. Hemorrhagic metalloproteinases from snake venoms. Pharmacol. Ther. 62:1994;325-372.
4. Brun J.G., Haland G., Haga H.J., Fagerhol M.K., Jonsson R. Effects of calprotectin in avridine-induced arthritis. Apmis. 103:1995;233-240.
5. Chacur M., Picolo G., Teixeira C.F., Cury Y. Bradykinin is involved in hyperalgesia induced by Bothrops jararaca venom. Toxicon. 40:2002;1047-1051.
6. Clissa P.B., Laing G.D., Theakston R.D., Mota I., Taylor M.J., Moura-da-Silva A.M. The effect of jararhagin, a metalloproteinase from Bothrops jararaca venom, on pro-inflammatory cytokines released by murine peritoneal adherent cells. Toxicon. 39:2001;1567-1573.
7. Costa E.P., Clissa P.B., Teixeira C.F., Moura-da-Silva A.M. Importance of metalloproteinases and macrophages in viper snake envenomation-induced local inflammation. Inflammation. 26:2002;13-17.
8. Cury Y., Teixeira C.F., Sudo L.S. Edematogenic responses induced by Bothrops jararaca venom in rats: role of lymphocytes. Toxicon. 32:1994;1425-1431.
9. Damas J., Liegeois J.F., Bourdon V. Involvement of 5-hydroxytryptamine and bradykinin in the hyperalgesia induced in rats by collagenase from Clostridium histolyticum. Naunyn. Schmiedebergs Arch Pharmacol. 355:1997;566-570.
10. Delabie J., de Wolf-Peeters C., van den Oord J.J., Desmet V.J. Differential expression of the calcium-binding proteins MRP8 and MRP14 in granulomatous conditions: an immunohistochemical study. Clin. Exp. Immunol. 81:1990;123-126.
11. Ferreira S.H. Peripheral analgesia: mechanism of the analgesic action of aspirin-like drugs and opiate-antagonists. Br. J. Clin. Pharmacol. 10(Suppl. 2):1980;237S-245S.
12. Fiorucci S., Distrutti E. Role of PAR2 in pain and inflammation. Trends Pharmacol. Sci. 23:2002;153-155.
13. Freemont P., Hogg N., Edgeworth J. Sequence identity. Nature. 339:1989;516.
14. Giorgi R., Pagano R.L., Amorim Dias M.A., Aguiar-Passeti T., Sorg C., Mariano M. Antinociceptive effect of the calcium-binding protein MRP-14 and the role played by neutrophils on the control of inflammatory pain. J. Leukoc. Biol. 64:1998;214-220.
15. Gipson T.S., Bless N.M., Shanley T.P., Crouch L.D., Bleavins M.R., Younkin E.M.et al. Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury. J. Immunol. 162:1999;3653-3662.
16. Goncalves L.R.C., Mariano M. Local haemorrhage induced by Bothrops jararaca venom: relationship to neurogenic inflammation. Mediat. Inflamm. 9:2000;101-107.
17. Gupta O.P., Sharma N., Chand D. A sensitive and relevant model for evaluating anti-inflammatory activity-papaya latex-induced rat paw inflammation. J. Pharmacol. Toxicol. Methods. 28:1992;15-19.
18. Gutierrez J.M., Rucavado A. Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. Biochimie. 82:2000;841-850.
19. Hessian P.A., Edgeworth J., Hogg N. MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J. Leukoc. Biol. 53:1993;197-204.
20. Hessian P.A., Wilkinson L., Hogg N. The S100 family protein MRP-14 (S100A9) has homology with the contact domain of high molecular weight kininogen. FEBS Lett. 371:1995;271-275.
21. Isaksen B., Fagerhol M.K. Calprotectin inhibits matrix metalloproteinases by sequestration of zinc. Mol. Pathol. 54:2001;289-292.
22. Johnston R.B. Jr., Chadwick D.A., Cohn Z.A. Priming of macrophages for enhanced oxidative metabolism by exposure to proteolytic enzymes. J. Exp. Med. 153:1981;1678-1683.
23. Katunuma N., Kido H. Biological functions of serine proteases in mast cells in allergic inflammation. J. Cell Biochem. 38:1988;291-301.
24. Kawabata A., Kawao N., Itoh H., Shimada C., Takebe K., Kuroda R.et al. Role of N-methyl-D-aspartate receptors and the nitric oxide pathway in nociception/hyperalgesia elicited by protease-activated receptor-2 activation in mice and rats. Neurosci. Lett. 329:2002;349-353.
25. Kerkhoff C., Klempt M., Sorg C. Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim. Biophys. Acta. 1448:1998;200-211.
26. Kitoh Y., Katsuramaki T., Tanaka H., Tanaka M., Kitabayashi N., Kataoka M.et al. Effect of SL-1010 (sodium hyaluronate with high molecular weight) on experimental osteoarthritis induced by intra-articularly applied papain in rabbits. Nippon Yakurigaku Zasshi. 100:1992;67-76.
27. Kligman D., Hilt D.C. The S100 protein family. Trends Biochem. Sci. 13:1988;437-443.
28. Kondo H., Kondo S., Ikezawa H., Murata R., Ohsaka A. Studies on the quantitative method for the determination of hemorrhagic activity of Habu snake venom. Jpn. J. Med. Sci. Biol. 13:1960;43-51.
29. Legat F.J., Griesbacher T., Lembeck F. Mediation by bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum. Br. J. Pharmacol. 112:1994;453-460.
30. Neurath H. Proteolytic processing and physiological regulation. Trends Biochem. Sci. 14:1989;268-271.
31. Neves-Ferreira A.G., Cardinale N., Rocha S.L., Perales J., Domont G.B. Isolation and characterization of DM40 and DM43, two snake venom metalloproteinase inhibitors from Didelphis marsupialis serum. Biochim. Biophys. Acta. 1474:2000;309-320.
32. Newton R.A., Hogg N. The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J. Immunol. 160:1998;1427-1435.
33. Odink K., Cerletti N., Bruggen J., Clerc R.G., Tarcsay L., Zwadlo G.et al. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature. 330:1987;80-82.
34. Pagano R.L., Dias M.A., Dale C.S., Giorgi R. Neutrophils and the calcium-binding protein MRP-14 mediate carrageenan-induced antinociception in mice. Mediat. Inflamm. 11:2002;203-210.
35. Paine M.J., Desmond H.P., Theakston R.D., Crampton J.M. Purification, cloning, and molecular characterization of a high molecular weight hemorrhagic metalloprotease, jararhagin, from Bothrops jararaca venom. Insights into the disintegrin gene family. J. Biol. Chem. 267:1992;22869-22876.
36. Perales J., Amorim C.Z., Rocha S.L., Domont G.B., Moussatche H. Neutralization of the oedematogenic activity of Bothrops jararaca venom on the mouse paw by an antibothropic fraction isolated from opossum (Didelphis marsupialis) serum. Agents Actions. 37:1992;250-259.
37. Raftery M.J., Harrison C.A., Alewood P., Jones A., Geczy C.L. Isolation of the murine S100 protein MRP14 (14. kDa migration-inhibitory-factor-related protein) from activated spleen cells: characterization of post-translational modifications and zinc binding Biochem. J. 316(Pt 1):1996;285-293.
38. Randall L.O., Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. 111:1957;209-219.
39. Rocha S.L., Frutuoso V.S., Domont G.B., Martins M.A., Moussatche H., Perales J. Inhibition of the hyperalgesic activity of Bothrops jararaca venom by an antibothropic fraction isolated from opossum (Didelphis marsupialis) serum. Toxicon. 38:2000;875-880.
40. Santhanagopalan V., Hahn B.L., Sohnle P.G. Resistance of zinc-supplemented Candida albicans cells to the growth inhibitory effect of calprotectin. J. Infect Dis. 171:1995;1289-1294.
41. Schafer B.W., Wicki R., Engelkamp D., Mattei M.G., Heizmann C.W. Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics. 25:1995;638-643.
42. Sohnle P.G., Hahn B.L., Santhanagopalan V. Inhibition of Candida albicans growth by calprotectin in the absence of direct contact with the organisms. J. Infect Dis. 174:1996;1369-1372.
43. Sohnle P.G., Hunter M.J., Hahn B., Chazin W.J. Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14). J. Infect Dis. 182:2000;1272-1275.
44. Sokal RR, Rohlf FJ. Biometry. New York: W.H. Freeman & Co.; 1981. p. 859.
45. Steinbakk M., Naess-Andresen C.F., Lingaas E., Dale I., Brandtzaeg P., Fagerhol M.K. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet. 336:1990;763-765.
46. Steinhoff M., Vergnolle N., Young S.H., Tognetto M., Amadesi S., Ennes H.S.et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat. Med. 6:2000;151-158.
47. Tanaka H., Kitoh Y., Katsuramaki T., Tanaka M., Kitabayashi N., Fujimori S.et al. Effects of SL-1010 (sodium hyaluronate with high molecular weight) on experimental osteoarthritis induced by intra-articularly applied papain in guinea pigs. Nippon Yakurigaku Zasshi. 100:1992;77-86.
48. Teixeira C.F., Cury Y., Oga S., Jancar S. Hyperalgesia induced by Bothrops jararaca venom in rats: role of eicosanoids and platelet activating factor (PAF). Toxicon. 32:1994;419-426.
49. Trebien H.A., Calixto J.B. Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom. Agents Actions. 26:1989;292-300.
50. Vergnolle N., Bunnett N.W., Sharkey K.A., Brussee V., Compton S.J., Grady E.F.et al. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat. Med. 7:2001;821-826.
51. Vergnolle N., Wallace J.L., Bunnett N.W., Hollenberg M.D. Protease-activated receptors in inflammation. Trends Pharmacol. Sci. 22:2001;146-152.
52. Vinegar R., Truax J.F., Selph J.L. Quantitative comparison of the analgesic and anti-inflammatory activities of aspirin, phenacetin and acetaminophen in rodents. Eur. J. Pharmacol. 37:1976;23-30.
53. Vinegar R., Truax J.F., Selph J.L. Quantitative studies of the pathway to acute carrageenan inflammation. Fed. Proc. 35:1976;2447-2456.
54. Vinegar R., Truax J.F., Selph J.L., Johnston P.R. New analgesic assay utilizing trypsin-induced hyperalgesia in the hind limb of the rat. J. Pharmacol. Methods. 23:1990;51-61.
55. Watt K.W., Brightman I.L., Goetzl E.J. Isolation of two polypeptides comprising the neutrophil-immobilizing factor of human leukocytes. Immunology. 48:1983;79-86.
56. Winder C.V., Wax I., Been M.A. Rapid foot volume measurements of unaesthetized rats and the question of the phenilbutazone effect on anaphylactoid edema. Arch. Int. Pharmacodyn. 112:1957;335-340.
57. Winter C.A., Kling P.J. Analgesic action of indomethacin in rats with trypsin-induced hyperalgesia. J. Pharm. Pharmacol. 32:1980;875-876.
58. Yoshinaga M., Yamamoto S., Kiyota S., Hayashi H. The natural mediator for PMN emigration in inflammation. IV. In vitro production of a chemotactic factor by papain from immunoglobulin G. Immunology. 22:1972;393-399.
59. Yui S., Mikami M., Tsurumaki K., Yamazaki M. Growth-inhibitory and apoptosis-inducing activities of calprotectin derived from inflammatory exudate cells on normal fibroblasts: regulation by metal ions. J. Leukoc. Biol. 61:1997;50-57.
60. Yui S., Mikami M., Yamazaki M. Induction of apoptotic cell death in mouse lymphoma and human leukemia cell lines by a calcium-binding protein complex, calprotectin, derived from inflammatory peritoneal exudate cells. J. Leukoc. Biol. 58:1995;650-658.
61. Yui S., Mikami M., Yamazaki M. Purification and characterization of the cytotoxic factor in rat peritoneal exudate cells: its identification as the calcium binding protein complex, calprotectin. J. Leukoc. Biol. 58:1995;307-316.
62. Yui S., Nakatani Y., Hunter M.J., Chazin W.J., Yamazaki M. Implication of extracellular zinc exclusion by recombinant human calprotectin (MRP8 and MRP14) from target cells in its apoptosis-inducing activity. Mediat. Inflamm. 11:2002;165-172.
63. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.